Christopher Wild: Let’s be practical
Understanding how cancer wreaks its havoc on the human body is important for the head of the International Agency for Research on Cancer, but his main concern is how to stop it. In the 30 [more]
Cover Story
Shelley Dolan: walking alongside patients
Nurses are not the only ones who care and can nurture, support and explain things to patients who are scared and vulnerable, says pioneering cancer nurse Shelley Dolan. But they are the only health professionals [more]
Marcel Verheij: Revolutionising radiotherapy
Could intelligent combinations of drugs and radiation take precision radiotherapy to new levels? Marcel Verheij believes so, but may struggle to prove it without a fairer share of funding In the mid-80s, radiotherapy looked doomed. [more]
Enriqueta Felip: breaking boundaries in lung cancer
Building a lung cancer team that works seamlessly to do the best for each patient was the biggest challenge in Enriqueta Felips career. Her focus today is on increasing collaboration across Europe, which she sees [more]
Jean-Charles Soria: Beyond the science
Phase I trials now play an essential role in treating patients with metastatic cancer, offering vital extra moves in the battle to outplay the disease, says Jean-Charles Soria. He warns, however, that not every patient [more]
Roger Stupp: What’s so ethical about strangling research?
Patients are losing out because the rules governing research are designed to restrain rather than facilitate. Its got to change, says Roger Stupp, who is frustrated that 10 years after helping set a new standard [more]
David Cameron: What do we really know about the quality of care we provide?
We wont improve cancer care until we know more about how well we are doing and how alternative approaches compare. It sounds obvious, but its not happening, says the real David Cameron Something in the [more]
Jim Watson: DNA revealed the causes, it may never reveal a cure
Nobel laureate Jim Watson is calling on the cancer community to take a long hard look at what has been achieved by blocking the molecular signals that drive individual cancers Sixty years after Jim Watson [more]
Semir Beslija: the sky’s the limit in Sarajevo
Semir Beslija’s tenacious efforts have built the Sarajevo Oncology Institute from zero’ at the end of the war, to the regional centre of excellence and trusted trials centre it is today. The taxi driver who [more]
Agnes Buzyn:protecting France’s AAA rating for cancer care
France’s relatively low profile on the European cancer stage belies a creative and innovative approach to research and care that other countries could learn from. Agnès Buzyn lifts the lid on how French cancer services [more]
Richard Sullivan: Why are we doing this?
Cancer policy is determined by opinions not evidence, with the loudest voice setting the agenda. This is the worry of Richard Sullivan, who is on a mission to open the discussion to voices beyond the [more]
Vincenzo Valentini: putting knowledge to work
Patients are being let down by a failure to integrate the knowledge we have to get the best possible results for each individual patient and for cancer patients as a whole. Vincenzo Valentini, the ESTRO [more]
Andreas Engert: Learning from Hodgkin’s
Hodgkin’s patients survive for longer but with more serious and lasting damage than almost any other group of cancer patients. Finding ways to address the problems of both current and future survivors can [more]